Authors: SWAIN SM ROWLAND J WEINFURT K BERG C LIPPMAN ME WALTON L EGAN E KING D SPERTUS I HONIG SF

Citation: Sm. Swain et al., INTENSIVE OUTPATIENT ADJUVANT THERAPY FOR BREAST-CANCER - RESULTS OF DOSE-ESCALATION AND QUALITY-OF-LIFE, Journal of clinical oncology, 14(5), 1996, pp. 1565-1572

Authors: SWAIN SM HONIG SF TEFFT MC WALTON L

Citation: Sm. Swain et al., A PHASE-II TRIAL OF PACLITAXEL (TAXOL(R)) AS FIRST LINE TREATMENT IN ADVANCED BREAST-CANCER, Investigational new drugs, 13(3), 1995, pp. 217-222

Authors: SWAIN SM HONIG SF EGAN E

Citation: Sm. Swain et al., CLINICAL BREAST-CANCER RESEARCH CORE, Breast cancer research and treatment, 31(2-3), 1994, pp. 371-375

Authors: SWAIN SM HONIG SF

Citation: Sm. Swain et Sf. Honig, MITOXANTRONE, 5-FU, AND LEUCOVORIN IN BREAST-CANCER, Medical and pediatric oncology, 22(6), 1994, pp. 370-374

Authors: MCLESKEY SW KUREBAYASHI J HONIG SF ZWIEBEL J LIPPMAN ME DICKSON RB KERN FG

Citation: Sw. Mcleskey et al., FIBROBLAST GROWTH FACTOR-IV TRANSFECTION OF MCF-7 CELLS PRODUCES CELL-LINES THAT ARE TUMORIGENIC AND METASTATIC IN OVARIECTOMIZED OR TAMOXIFEN-TREATED ATHYMIC NUDE-MICE, Cancer research, 53(9), 1993, pp. 2168-2177